Lantern Pharma (LTRN) Reports Q1 Loss of $0.51
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: LTRN) | Delayed: 0.64 -0.02 (3.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.66 | 52 Week High | $ | |||
| Open | $0.70 | 52 Week Low | $ | |||
| Day High | $0.74 | P/E | N/A | |||
| Day Low | $0.64 | EPS | $ | |||
| Volume | 176,071 | |||||
